Sungkyunkwan University, KIST researchers develop innovative anticancer platform
A Sungkyunkwan University research team has developed an innovative cancer treatment platform in collaboration with researchers at the Korea Institute of Science and Technology (KIST). Sungkyunkwan University said the platform is designed to simultaneously identify cancer cells and the surrounding cells that support them and block communication between the two at its source by suppressing the…
Sungkyunkwan University researchers, in partnership with scientists from the Korea Institute of Science and Technology (KIST), have developed an innovative anticancer platform. The platform aims to simultaneously identify cancer cells and the neighboring cells that support them, and block communication between the two at their source. This is achieved by suppressing the production of extracellular vesicles, which play a crucial role in cancer cell growth and spread.
Professor Yang Yoo-soo, from Sungkyunkwan University's department of integrative biotechnology, led the research team. They collaborated with a team headed by Dr. Shim Man-kyu at KIST. The tumor microenvironment is a complex community comprising cancer cells, cancer-associated fibroblasts, and various immune cells. These cells communicate with one another by exchanging tiny packages known as extracellular vesicles.
These vesicles carry signaling molecules between cells, giving cancer cells advantages that promote their growth and spread to other organs.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
